Profil
Dr. Petter Björquist is a Chief Executive Officer at Verigraft AB and a Chief Executive Officer at NovaHep AB. He is on the Board of Directors at ATMP Sweden, Phase Holographic Imaging AB and Stimuliver ApS.
Dr. Björquist was previously employed as a Vice President-Regenerative Medicine by Takara Bio Europe AB.
Postes actifs de Petter Björquist
| Sociétés | Poste | Début |
|---|---|---|
| PHASE HOLOGRAPHIC IMAGING PHI AB | Directeur/Membre du Conseil | - |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services Provides stem-cell research for gene therapy of liver diseases | Directeur Général | - |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Directeur Général | 01/02/2014 |
Anciens postes connus de Petter Björquist
| Sociétés | Poste | Fin |
|---|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Corporate Officer/Principal | 01/01/2014 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services Provides stem-cell research for gene therapy of liver diseases | Commercial Services |
Phase Holographic Imaging AB
Phase Holographic Imaging AB BiotechnologyHealth Technology Develops and manufactures imaging microscopes and cell analyzers | Health Technology |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Health Technology |
















